Equinox Gold Corp [AMEX: EQX] plunged by -$0.41 during the normal trading session on while it closed the day at $4.15. The company report on February 21, 2024 at 9:08 PM that Equinox Gold Reports Q4 and Fiscal 2023 Financial and Operating Results, Provides 2024
Parsons Corp [NYSE: PSN] traded at a high on Thursday, posting a 5.51 gain after which it closed the day’ session at $79.44. The company report on February 22, 2024 at 7:00 AM that Parsons Announces Pricing Of $700.0 Million Of Convertible Senior Notes Due
Ocular Therapeutix Inc [NASDAQ: OCUL] price surged by 28.99 percent to reach at $2.18. The company report on February 22, 2024 at 7:32 AM that Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer. The
Five9 Inc [NASDAQ: FIVN] loss -13.41% or -9.53 points to close at $61.52 with a heavy trading volume of 6608536 shares. The company report on February 22, 2024 at 4:05 PM that Five9 Announces Upcoming Conference Participation. Five9, Inc. (NASDAQ:FIVN), the Intelligent CX Platform provider,
Weyerhaeuser Co. [NYSE: WY] closed the trading session at $33.69. The company report on February 15, 2024 at 4:30 PM that Stockfish to Represent Weyerhaeuser at Upcoming Investor Conferences in March. Devin Stockfish, president and chief executive officer of Weyerhaeuser Company (NYSE: WY), will represent
Hims & Hers Health Inc [NYSE: HIMS] jumped around 0.04 points on Thursday, while shares priced at $9.45 at the close of the session, up 0.43%. The company report on February 20, 2024 at 8:00 AM that Hims & Hers Names Dan Kenger as the
SM Energy Co [NYSE: SM] stock went on an upward path that rose over 4.66% on Thursday, amounting to a one-week price increase of more than 10.12%. The company report on February 21, 2024 at 4:30 PM that SM ENERGY ANNOUNCES THE APPOINTMENT OF BARTON
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] gained 21.10% on the last trading session, reaching $18.54 price per share at the time. The company report on February 22, 2024 at 7:00 AM that Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results. Reported $380.8 million
Cogent Biosciences Inc [NASDAQ: COGT] surged by $0.39 during the normal trading session on while it closed the day at $8.95. The company report on February 22, 2024 at 2:30 PM that Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in
TG Therapeutics Inc [NASDAQ: TGTX] traded at a high on Thursday, posting a 3.23 gain after which it closed the day’ session at $13.44. The company report on February 20, 2024 at 7:30 AM that TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab)
© 2024, Powered by Smart TechOne
